GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Cash from Investing Activities came in at -$115.0 million in Q2 2026, up 48.43% on a YoY basis from -$77.5 million in Q2 2025, and up 95.4% quarter-over-quarter from -$2.5 billion in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Cash from Investing Activities for 5 consecutive years, with -$115.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities rose 48.43% year-over-year to -$115.0 million; the trailing twelve-month figure through Jun 2026 stood at -$3.0 billion (down 201.09% YoY), and the FY2025 full-year result was -$1.0 billion, down 14.55% from the prior year.
- Cash from Investing Activities rose to -$115.0 million in Q2 2026 per GEHC's latest filing, from -$2.5 billion in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$84.0 million in Q2 2023 and bottomed at -$2.5 billion in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$307.3 million across 5 years, with a median of -$142.5 million in 2024.
- The widest YoY moves for Cash from Investing Activities: up 48.43% in 2026, down 514.25% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$95.0 million in 2022, then rose by 7.37% to -$88.0 million in 2023, then sank by 172.73% to -$240.0 million in 2024, then fell by 12.08% to -$269.0 million in 2025, then surged by 57.25% to -$115.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$115.0 million, -$2.5 billion, and -$269.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.54 Bn | 27.44 Bn | 2.18 Bn | -115.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | -2.02 Mn |
| 3 | Heartflow | 4.04 Bn | 3.66 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.59 Bn | 2.41 Bn | 107.80 Mn | -4.00 Mn |
| 5 | Butterfly Network | 1.96 Bn | 1.84 Bn | 23.29 Mn | -974,000.00 |
| 6 | Ceribell | 928.74 Mn | 799.48 Mn | 25.94 Mn | -606,000.00 |
| 7 | QuidelOrtho | 866.04 Mn | 742.64 Mn | - | -107.30 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | -6.30 Mn |
| 9 | Prenetics Global | 339.99 Mn | 280.94 Mn | 30.20 Mn | 41.68 Mn |
| 10 | CapsoVision | 318.60 Mn | 309.52 Mn | 1.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -115.00 Mn |
| Mar 31, 2026 | -2.50 Bn |
| Dec 31, 2025 | -269.00 Mn |
| Sep 30, 2025 | -148.00 Mn |
| Jun 30, 2025 | -223.00 Mn |
| Mar 31, 2025 | -407.00 Mn |
| Dec 31, 2024 | -240.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -349.00 Mn |
| Mar 31, 2024 | -188.00 Mn |
| Dec 31, 2023 | -88.00 Mn |
| Sep 30, 2023 | -120.00 Mn |
| Jun 30, 2023 | -84.00 Mn |
| Mar 31, 2023 | -266.00 Mn |
| Dec 31, 2022 | -95.00 Mn |
| Sep 30, 2022 | -118.00 Mn |
| Jun 30, 2022 | -85.00 Mn |
| Mar 31, 2022 | -100.00 Mn |